The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Defining the relationship between COPD and CVD: what are the implications for clinical practice?
Open accessAbstract
Cardiovascular diseases (CVDs) are arguably the most important comorbidities in chronic obstructive pulmonary disease (COPD). CVDs are common in people with COPD, and their presence is associated with increased risk for hospitalization, longer length of stay and all-cause and CVD-related mortality. The economic burden associated with CVD in this population is considerable and the cumulative cost of treating comorbidities may even exceed that of treating COPD itself. Our understanding of the biological mechanisms that link COPD and various forms of CVD has improved significantly over the past decade. But despite broad acceptance of the prognostic significance of CVDs in COPD, there remains widespread under-recognition and undertreatment of comorbid CVD in this population. The reasons for this are unclear; however institutional barriers and a lack of evidence-based guidelines for the management of CVD in people with COPD may be contributory factors. In this review, we summarize current knowledge relating to the prevalence and incidence of CVD in people with COPD and the mechanisms that underlie their coexistence. We discuss the implications for clinical practice and highlight opportunities for improved prevention and treatment of CVD in people with COPD. While we advocate more active assessment for signs of cardiovascular conditions across all age groups and all stages of COPD severity, we suggest targeting those aged under 65 years. Evidence indicates that the increased risks for CVD are particularly pronounced in COPD patients in mid-to-late-middle-age and thus it is in this age group that the benefits of early intervention may prove to be the most effective.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Barnett, K., Mercer, S. W., Norbury, M., Watt, G., Wyke, S., & Guthrie, B. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60240-2 · Cited by 6,972
Cohen, A. J., Brauer, M., Burnett, R., Anderson, H. R., Frostad, J., Estep, K., Balakrishnan, K., Brunekreef, B., Dandona, L., Dandona, R., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30505-6 · Cited by 6,583
Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness
Vlachopoulos, C., Aznaouridis, K., & Stefanadis, C. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.10.061 · Cited by 4,165
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
Paulus, W. J., & Tschöpe, C. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.092 · Cited by 3,564 · cited 1×
“49 COPD is considered to be a consequence of a heightened inflammatory response to inhaled cigarette smoke (and other noxious particles), leading to disruption of normal lung defence and repair mechanisms, narrowing and remodelling of the small airways, and destruction of the lung parenchyma…”
BackgroundSoriano, J. B., Abajobir, A. A., Abate, K. H., Abera, S. F., Agrawal, A., Ahmed, M. B., Aichour, A. N., Aichour, I., Aichour, M. T. E., Alam, K., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30293-x · Cited by 2,538
Gan, W. Q. (2004) · Thorax · doi:10.1136/thx.2003.019588 · Cited by 1,838
Anthonisen, N. R. (1994) · JAMA · doi:10.1001/jama.1994.03520190043033 · Cited by 1,341
Comorbidities and Risk of Mortality in Patients with Chronic Obstructive Pulmonary Disease
Divo, M., Cote, C., de Torres, J. P., Casanova, C., Marin, J. M., Pinto-Plata, V., Zulueta, J., Cabrera, C., Zagaceta, J., Hunninghake, G., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201201-0034oc · Cited by 1,275
Global and regional estimates of COPD prevalence: Systematic review and meta–analysis
Adeloye, D., Chua, S., Lee, C., Basquill, C., Papana, A., Theodoratou, E., Nair, H., Gasevic, D., Sridhar, D., Campbell, H., et al. (2015) · Journal of Global Health · doi:10.7189/jogh.05.020415 · Cited by 1,264
Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD
Mannino, D. M., Thorn, D., Swensen, A., & Holguin, F. (2008) · European Respiratory Journal · doi:10.1183/09031936.00012408 · Cited by 1,184
Sin, D. D., & Man, S. F. P. (2003) · Circulation · doi:10.1161/01.cir.0000056767.69054.b3 · Cited by 1,082
Endothelial Cell Senescence in Human Atherosclerosis: Role of Telomere in Endothelial Dysfunction
Minamino, T., Miyauchi, H., Yoshida, T., Ishida, Y., Yoshida, H., & Komuro, I. (2002) · Circulation · doi:10.1161/01.cir.0000013836.85741.17 · Cited by 1,061
Mortality in COPD: role of comorbidities
Sin, D. D., Anthonisen, N. R., Soriano, J. B., & Agusti, A. G. (2006) · European Respiratory Journal · doi:10.1183/09031936.00133805 · Cited by 1,052
Chronic obstructive pulmonary disease
Rabe, K. F., & Watz, H. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31222-9 · Cited by 960
Vanfleteren, L. E. G. W., Spruit, M. A., Groenen, M., Gaffron, S., van Empel, V. P. M., Bruijnzeel, P. L. B., Rutten, E. P. A., Op ’t Roodt, J., Wouters, E. F. M., & Franssen, F. M. E. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201209-1665oc · Cited by 828
Chen, W., Thomas, J., Sadatsafavi, M., & FitzGerald, J. M. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00241-6 · Cited by 718
Benetos, A., Okuda, K., Lajemi, M., Kimura, M., Thomas, F., Skurnick, J., Labat, C., Bean, K., & Aviv, A. (2001) · Hypertension · doi:10.1161/01.hyp.37.2.381 · Cited by 620
Cardiovascular Disease in Patients with Chronic Obstructive Pulmonary Disease, Saskatchewan Canada
Curkendall, S. M., deLuise, C., Jones, J. K., Lanes, S., Stang, M. R., Goehring, E., & She, D. (2006) · Annals of Epidemiology · doi:10.1016/j.annepidem.2005.04.008 · Cited by 616
Sidney, S., Sorel, M., Quesenberry, C. P., DeLuise, C., Lanes, S., & Eisner, M. D. (2005) · Chest · doi:10.1378/chest.128.4.2068 · Cited by 540
Impairment of Endothelium-Dependent Pulmonary-Artery Relaxation in Chronic Obstructive Lung Disease
Dinh-Xuan, A. T., Higenbottam, T. W., Clelland, C. A., Pepke-Zaba, J., Cremona, G., Butt, A. Y., Large, S. R., Wells, F. C., & Wallwork, J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199105303242203 · Cited by 528
Alveolar Cell Senescence in Patients with Pulmonary Emphysema
Tsuji, T., Aoshiba, K., & Nagai, A. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200509-1374oc · Cited by 527
Vestbo, J., Anderson, J. A., Brook, R. D., Calverley, P. M. A., Celli, B. R., Crim, C., Martinez, F., Yates, J., & Newby, D. E. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30069-1 · Cited by 483
Sciurba, F. C., Rogers, R. M., Keenan, R. J., Slivka, W. A., Gorcsan, J., Ferson, P. F., Holbert, J. M., Brown, M. L., & Landreneau, R. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604253341704 · Cited by 462
Use of Plasma Biomarkers at Exacerbation of Chronic Obstructive Pulmonary Disease
Hurst, J. R., Donaldson, G. C., Perera, W. R., Wilkinson, T. M. A., Bilello, J. A., Hagan, G. W., Vessey, R. S., & Wedzicha, J. A. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200604-506oc · Cited by 454
Feary, J. R., Rodrigues, L. C., Smith, C. J., Hubbard, R. B., & Gibson, J. E. (2010) · Thorax · doi:10.1136/thx.2009.128082 · Cited by 445
Celli, B. R., Locantore, N., Yates, J., Tal-Singer, R., Miller, B. E., Bakke, P., Calverley, P., Coxson, H., Crim, C., Edwards, L. D., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201110-1792oc · Cited by 432
C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease
Man, S. F. P. (2006) · Thorax · doi:10.1136/thx.2006.059808 · Cited by 397
Cardiovascular Comorbidity in COPD
Müllerova, H., Agusti, A., Erqou, S., & Mapel, D. W. (2013) · Chest · doi:10.1378/chest.12-2847 · Cited by 358
Simvastatin for the Prevention of Exacerbations in Moderate-to-Severe COPD
Criner, G. J., Connett, J. E., Aaron, S. D., Albert, R. K., Bailey, W. C., Casaburi, R., Cooper, J. A. D., Curtis, J. L., Dransfield, M. T., Han, M. K., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1403086 · Cited by 347
Lung function in early adulthood and health in later life: a transgenerational cohort analysis
Agustí, A., Noell, G., Brugada, J., & Faner, R. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30434-4 · Cited by 346
Shortened Telomeres in Circulating Leukocytes of Patients with Chronic Obstructive Pulmonary Disease
Savale, L., Chaouat, A., Bastuji-Garin, S., Marcos, E., Boyer, L., Maitre, B., Sarni, M., Housset, B., Weitzenblum, E., Matrat, M., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200809-1398oc · Cited by 322
C-reactive protein levels and clinically important predictive outcomes in stable COPD patients
de Torres, J. P., Cordoba-Lanus, E., López-Aguilar, C., Muros de Fuentes, M., Montejo de Garcini, A., Aguirre-Jaime, A., Celli, B. R., & Casanova, C. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00109605 · Cited by 297
Chronic obstructive pulmonary disease and comorbidities
Decramer, M., & Janssens, W. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(12)70060-7 · Cited by 291
Marked Sympathetic Activation in Patients with Chronic Respiratory Failure
HEINDL, S., LEHNERT, M., CRIÉE, C.-P., HASENFUSS, G., & ANDREAS, S. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.4.2007085 · Cited by 287
Senescence in COPD and Its Comorbidities
Barnes, P. J. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034314 · Cited by 266
Mortality in COPD: Causes, Risk Factors, and Prevention
Berry, C. E., & Wise, R. A. (2010) · COPD: Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2010.510160 · Cited by 257
Cardiovascular Disease in COPD
Maclay, J. D., & MacNee, W. (2013) · Chest · doi:10.1378/chest.12-0938 · Cited by 257
Sirtuins, Cell Senescence, and Vascular Aging
Kida, Y., & Goligorsky, M. S. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.11.022 · Cited by 256
Chronic Obstructive Pulmonary Disease and Cardiac Diseases. An Urgent Need for Integrated Care
Roversi, S., Fabbri, L. M., Sin, D. D., Hawkins, N. M., & Agustí, A. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201604-0690so · Cited by 251
Mills, N. L., Miller, J. J., Anand, A., Robinson, S. D., Frazer, G. A., Anderson, D., Breen, L., Wilkinson, I. B., McEniery, C. M., Donaldson, K., et al. (2008) · Thorax · doi:10.1136/thx.2007.083493 · Cited by 250
Chronic obstructive pulmonary disease and cardiovascular disease
Bhatt, S. P., & Dransfield, M. T. (2013) · Translational Research · doi:10.1016/j.trsl.2013.05.001 · Cited by 228
Management of chronic obstructive pulmonary disease beyond the lungs
Vanfleteren, L. E. G. W., Spruit, M. A., Wouters, E. F. M., & Franssen, F. M. E. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)00097-7 · Cited by 210
COPD and stroke: are systemic inflammation and oxidative stress the missing links?
Austin, V., Crack, P. J., Bozinovski, S., Miller, A. A., & Vlahos, R. (2016) · Clinical Science · doi:10.1042/cs20160043 · Cited by 190
Gershon, A., Croxford, R., Calzavara, A., To, T., Stanbrook, M. B., Upshur, R., & Stukel, T. A. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1016 · Cited by 184
Rapid decline in FEV1. A new risk factor for coronary heart disease mortality.
Tockman, M. S., Pearson, J. D., Fleg, J. L., Metter, E. J., Kao, S. Y., Rampal, K. G., Cruise, L. J., & Fozard, J. L. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.2.7842197 · Cited by 171
Chronic Obstructive Pulmonary Disease and the Risk of Stroke. The Rotterdam Study
Portegies, M. L. P., Lahousse, L., Joos, G., Albert Hofman, D., Koudstaal, P. J., Stricker, B. H. C., Brusselle, G., & Ikram, M. A. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201505-0962oc · Cited by 169
Chronic obstructive pulmonary disease and cerebrovascular disease: A comprehensive review
Lahousse, L., Tiemeier, H. W., Ikram, M. A., & Brusselle, G. (2015) · Respiratory Medicine · doi:10.1016/j.rmed.2015.07.014 · Cited by 150
Cardiac dysfunction during exacerbations of chronic obstructive pulmonary disease
MacDonald, M., Shafuddin, E., King, P. T., Chang, C. L., Bardin, P. G., & Hancox, R. J. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00509-3 · Cited by 150
Pujades‐Rodríguez, M., George, J., Shah, A. D., Rapsomaniki, E., Denaxas, S., West, R., Smeeth, L. L., Timmis, A., & Hemingway, H. (2014) · International Journal of Epidemiology · doi:10.1093/ije/dyu218 · Cited by 146
Wright, J. R., Petty, T. L., & Thurlbeck, W. M. (1992) · Lung · doi:10.1007/bf00175982 · Cited by 145
Dong, Y., Lin, H.-H., Shau, W., Wu, Y., Chang, C., & Lai, M. (2012) · Thorax · doi:10.1136/thoraxjnl-2012-201926 · Cited by 140
Chronic obstructive pulmonary disease and atrial fibrillation: An unknown relationship
Goudis, C. A. (2017) · Journal of Cardiology · doi:10.1016/j.jjcc.2016.12.013 · Cited by 137
Agarwal, S. K., HEISS, G. M., Barr, R. G., Chang, P. P., Loehr, L. R., Chambless, L. E., Shahar, E., Kitzman, D. W., & Rosamond, W. D. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs016 · Cited by 132
Rothnie, K., Yan, R., Smeeth, L. L., & Quint, J. K. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-007824 · Cited by 126
Self-citationQuint, J. K., Herrett, E. L., Bhaskaran, K., Timmis, A., Hemingway, H., Wedzicha, J. A., & Smeeth, L. L. (2013) · BMJ · doi:10.1136/bmj.f6650 · Cited by 126
Self-citationPatel, A. R. C., Donaldson, G. C., Mackay, A. J., Wedzicha, J. A., & Hurst, J. R. (2011) · CHEST Journal · doi:10.1378/chest.11-0853 · Cited by 126
Vivodtzev, I., Tamisier, R., Baguet, J.-P., Borel, J., Levy, P. A., & Pépin, J. (2014) · CHEST Journal · doi:10.1378/chest.13-1809 · Cited by 114
Systemic elastin degradation in chronic obstructive pulmonary disease
Maclay, J. D., McAllister, D., Rabinovich, R., Haq, I., Maxwell, S., Hartland, S. N., Connell, M., Murchison, J. T., van Beek, E. J. R., Gray, R. D., et al. (2012) · Thorax · doi:10.1136/thoraxjnl-2011-200949 · Cited by 111
Houben‐Wilke, S., Jörres, R. A., Bals, R., Franssen, F. M. E., Gläser, S., Holle, R., Karch, A., Koch, A., MAGNUSSEN, H., Obst, A., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201602-0354oc · Cited by 111
Comorbidities and Burden of COPD: A Population Based Case-Control Study
Baty, F., Putora, P. M., Isenring, B. D., Blum, T. G., & Brutsche, M. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063285 · Cited by 110
Vanfleteren, L. E. G. W., Spruit, M. A., Groenen, M. T. J., Bruijnzeel, P. L. B., Taib, Z., Rutten, E. P. A., Roodt, J. O. ’., Akkermans, M. A., Wouters, E. F. �., & Franssen, F. M. E. (2013) · European Respiratory Journal · doi:10.1183/09031936.00169313 · Cited by 108
Role of Lung Maintenance Program in the Heterogeneity of Lung Destruction in Emphysema
Tuder, R. M., Yoshida, T., Fijalkowka, I., Biswal, S. S., & Petrache, I. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200605-124sf · Cited by 106
Cardiac effects of current treatments of chronic obstructive pulmonary disease
Lahousse, L., Verhamme, K. M. C., Stricker, B. H. C., & Brusselle, G. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00518-4 · Cited by 99
Chronic obstructive pulmonary disease: a modifiable risk factor for cardiovascular disease?
Stone, I. S., Barnes, N. C., & Petersen, S. E. (2012) · Heart · doi:10.1136/heartjnl-2012-301759 · Cited by 89
Beta-blockers in COPD: time for reappraisal
Lipworth, B. J., Wedzicha, J. A., Devereux, G. S., Vestbo, J., & Dransfield, M. T. (2016) · European Respiratory Journal · doi:10.1183/13993003.01847-2015 · Cited by 89
Polverino, F., Laucho-Contreras, M. E., Petersen, H. V., Bijol, V., Sholl, L. M., Choi, M. E., Divo, M. J., Pinto-Plata, V., Chetta, A. A., Tesfaigzi, Y., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201609-1765oc · Cited by 88
Derivation and validation of clinical phenotypes for COPD: a systematic review
Pinto, L., Alghamdi, M. A., Benedetti, A., Zaihra, T., Landry, T., & Bourbeau, J. (2015) · Respiratory Research · doi:10.1186/s12931-015-0208-4 · Cited by 87
Coronary artery disease concomitant with chronic obstructive pulmonary disease
Roversi, S., Roversi, P., Spadafora, G., Rossi, R., & Fabbri, L. M. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12181 · Cited by 84
Co-morbidities of COPD in primary care: frequency, relation to COPD, and treatment consequences
van der Molen, T. (2010) · Primary Care Respiratory Journal · doi:10.4104/pcrj.2010.00053 · Cited by 80
Lung Function Abnormalities in Smokers with Ischemic Heart Disease
Franssen, F. M. E., Soriano, J. B., Roche, N., Bloomfield, P. H., Brusselle, G., Fabbri, L. M., Rio, F. G., Kearney, M. T., Kwon, N., Lundbäck, B., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201512-2480oc · Cited by 80
Rothnie, K., Smeeth, L. L., Herrett, E. L., Pearce, N. E., Hemingway, H., Wedzicha, J. A., Timmis, A., & Quint, J. K. (2015) · Heart · doi:10.1136/heartjnl-2014-307251 · Cited by 79
Self-citationCardiovascular Morbidity in COPD: A Study of the General Population
Lange, P., Møgelvang, R., Marott, J. L., Vestbo, J., & Jensen, J. S. (2010) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412550903499506 · Cited by 69
Zhang, W., Zhang, Y., Li, C., Jones, P., Wang, C., & Ye, F. (2017) · CHEST Journal · doi:10.1016/j.chest.2017.08.015 · Cited by 69
Calverley, P. M. A., Anderson, J. A., Brook, R. D., Crim, C. C., Gallot, N., Kilbride, S., Martínez, F. J., Yates, J., Newby, D. E., Vestbo, J., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201610-2086oc · Cited by 65
Engström, G., Hedblad, B., Janzon, L., & Valind, S. (2000) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/204748730000700404 · Cited by 63
Camiciottoli, G., Bigazzi, F., Magni, C., Bonti, V., Diciotti, S., Bartolucci, M., Mascalchi, M., & Pistolesi, M. (2016) · International Journal of COPD · doi:10.2147/copd.s111724 · Cited by 61
Parikh, M. A., Pistenmaa, C. L., Hoffman, E. A., Schwartz, J. E., Madrigano, J., Austin, J. H. M., Kalhan, R., Lovasi, G. S., Watson, K. E., Stukovsky, K. H., et al. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201604-317oc · Cited by 53
Brook, R. D., Anderson, J. A., Calverley, P. M. A., Celli, B. R., Crim, C. C., Denvir, M. A., Magder, S. A., Martínez, F. J., Rajagopalan, S., Vestbo, J., et al. (2017) · Heart · doi:10.1136/heartjnl-2016-310897 · Cited by 53
Chronic Obstructive Pulmonary Disease and the Risk of Stroke
Morgan, A. D., Sharma, C., Rothnie, K., Potts, J., Smeeth, L. L., & Quint, J. K. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201611-932sr · Cited by 46
Self-citationVitamin K deficiency: the linking pin between COPD and cardiovascular diseases?
Piscaer, I., Wouters, E. F. �., Vermeer, C., Janssens, W., Franssen, F. M. E., & Janssen, R. (2017) · Respiratory Research · doi:10.1186/s12931-017-0673-z · Cited by 45
Takahashi, S., & Betsuyaku, T. (2015) · Respiratory Investigation · doi:10.1016/j.resinv.2015.05.005 · Cited by 42
John, M., Cockcroft, J. R., McKeever, T. M., Coward, W. R., Shale, D. J., Johnson, S. R., Thornton, J., Harrison, T. W., Knox, A. J., & Bolton, C. E. (2015) · International Journal of COPD · doi:10.2147/copd.s76061 · Cited by 39
Marchetti, N. T., CICCOLELLA, D. E., Jacobs, M. R., Crookshank, A., Gaughan, J. P., Kashem, M. A., Bové, A. A., & Criner, G. J. (2011) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2011.558541 · Cited by 34
Yin, L., Lensmar, C., Ingelsson, E., & Bäck, M. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.03.140 · Cited by 30
Lung Elastic Recoil Does Not Correlate With Pulmonary Hemodynamics in Severe Emphysema
Falk, J., Martin, U. J., Scharf, S. M., & Criner, G. J. (2007) · CHEST Journal · doi:10.1378/chest.07-0041 · Cited by 21
Cardiovascular disease in COPD: a call for action
Bhatt, S. P., Wells, J. M., & Dransfield, M. T. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70197-3 · Cited by 18
Chen, R., Lin, L., Jing-wei, T., Zeng, B., Zhang, L., Chen, X., & Yan, H. (2015) · PubMed · doi:10.3978/j.issn.2072-1439.2015.07.08 · Cited by 14
Cited by
Cardiovascular disease and COPD: dangerous liaisons?
Rabe, K. F., Hurst, J. R., & Suissa, S. (2018) · European Respiratory Review · doi:10.1183/16000617.0057-2018 · Cited by 410
Stemmer, A., Shadmi, R., Bregman-Amitai, O., Chettrit, D., Blagev, D., Orlovsky, M., Deutsch, L., & Elnekave, E. (2020) · PLOS ONE · doi:10.1371/journal.pone.0236021 · Cited by 27
“Finally, a specific diagnosis of emphysema can also be made from the screening LDCT, which is by itself a risk factor for CVD [11], this screening could also lead to other disease specific interventions for pulmonary disease as well as CVD.”
Background
Metadata
- Authors
- Morgan, A. D., Zakeri, R., & Quint, J. K.
- Venue
- Therapeutic Advances in Respiratory Disease
- Publisher
- SAGE Publications
- Published
- 2018-01-01
- Volume
- 12
- Pages
- 1753465817750524-1753465817750524
- ISSN
- 1753-4658 (ISSN-L)
- 1753-4666
- OpenAlex
- W2794221242
- Cited by
- 337
- References
- 88
- FWCI
- 17.42
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.